Michael C. Burger

Goethe University Frankfurt — Germany

Medicine · Health Sciences

19h-index2.2kcitations127works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(47), CAR-T cell therapy research(27), Immunotherapy and Immune Responses(18), Heat shock proteins research(15), Immune Cell Function and Interaction(15)

Publications126 total

Comparative cross-methodological analysis of the IDH-wildtype glioblastoma tumor microenvironment
Journal of Cancer Research and Clinical Oncology·2026Open Access
Impact of parental adverse childhood experiences on children’s healthcare utilisation: a systematic review
Journal of Epidemiology & Community Health·2025Open Access
EPCO-28. THE MOLECULAR LANDSCAPE AND ITS PROGNOSTIC IMPLICATIONS IN ADULT PAPILLARY TUMORS OF THE PINEAL REGION - A MULTICENTER YOUNGNOA INVESTIGATION
Neuro-Oncology·2025
IMMU-15. Local CAR-NK cell therapy in combination with systemic checkpoint inhibition induces anti-tumor responses even in distant tumor locations in an immunocompetent glioblastoma mouse model
Neuro-Oncology·2025Open Access
CTIM-15. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: TREATMENT STRATEGY OPTIMIZATION IN THE PHASE 1/2 STUDY EOGBM1-18 / ROSALIE (NCT04116658)
Neuro-Oncology·2025Open Access
Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures
Immunity·2025· 9 citedOpen Access
P18.15.A IMMUNOCOMPETENT GLIOBLASTOMA ORGANOIDS FOR PERSONALIZED IMMUNE PROFILING
Neuro-Oncology·2025Open Access
P08.23.A CAR-ENGINEERED PRIMARY NK CELLS SHOW PROMISING EFFECTS AS TARGETED THERAPY AGAINST EGFR-POSITIVE GLIOBLASTOMA
Neuro-Oncology·2025Open Access
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial
Nature Medicine·2025· 6 citedOpen Access
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort
Cancer·2025· 3 citedOpen Access
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation
Neuro-Oncology·2025· 3 citedOpen Access
Susceptibility- and T2*-weighted MRI features of CNS large B-cell lymphoma in a large single-center cohort: prevalence, patterns, and clinical associations
Journal of Neuro-Oncology·2025Open Access
Engineered AAV9 as <i>in vivo</i> gene delivery platform for the selective transduction of TME cell subsets
2025Open Access
The impact of parental adverse childhood experiences on children’s healthcare utilisation: a systematic review
2025· 1 citedOpen Access
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma
British Journal of Cancer·2025· 10 citedOpen Access
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
QOL-14. HEALTH-RELATED QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN SURVIVORS OF OLIGODENDROGLIOMA: AN INTERNATIONAL CROSS-SECTIONAL INVESTIGATION
Neuro-Oncology·2024Open Access
TMIC-39. SPATIAL MULTIOMICS PROFILING REVEALS HETEROGENEITY OF B:T CELL INTERACTIONS AND PLASMA CELL FORMATION IN TERTIARY LYMPHOID STRUCTURES IN HUMAN GLIOMAS
Neuro-Oncology·2024Open Access
CTIM-04. MODULATION OF THE INTRATUMORAL IMMUNE MICROENVIRONMENT BY LOCAL THERAPY WITH NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Neuro-Oncology·2024Open Access
CTIM-08. FIRST IN HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA (GBM): FIRST RESULTS FROM THE DOSE ESCALATION PHASE
Neuro-Oncology·2024Open Access
page 1 of 7Next →

Frequent Co-authors

Joachim P. Steinbach(21), Patrick N. Harter(17), Iris Mildenberger(15), Winfried S. Wels(10), Wolfgang Wick(9), Marlies Wagner(9), Michael Ronellenfitsch(9), Ulrich Herrlinger(9), Ghazaleh Tabatabai(9), Michel Mittelbronn(8), Torsten Tonn(8), Christian Senft(8), Oliver Bähr(8), Karl H. Plate(7), Elke Hattingen(7), Jörg Steinbach(7), F Straßheimer(7), Antje Wick(7), Jadranka Macas(6), Yvonne Reiss(6)